These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16759529)

  • 1. [Detection of expression of p53, p16, and cyclooxygenase 2 in pancreatic cancer by tissue microarray and correlation among these three genes].
    Li YM; Yu ZH; Li L; Xu P; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):939-42. PubMed ID: 16759529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.
    Xu L; Li YM; Yu CH; Li L; Liu YS; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):138-42. PubMed ID: 16481301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray.
    Liu YS; Yu CH; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Li YM; Jun Gao H
    J Dig Dis; 2007 Aug; 8(3):133-8. PubMed ID: 17650224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of tissue microarray p53, p16 and cyclooxygenase-2 in gastric cancer].
    Yu CH; Li L; Li YM; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):658-60. PubMed ID: 17074152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
    Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
    Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
    Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
    Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.
    Chen YJ; Shih LS; Chen YM
    Int J Oncol; 1998 Aug; 13(2):249-54. PubMed ID: 9664118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
    J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.
    Ohtsubo K; Watanabe H; Yamaguchi Y; Hu YX; Motoo Y; Okai T; Sawabu N
    J Gastroenterol; 2003; 38(7):663-71. PubMed ID: 12898359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
    de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between tumor suppressor genes p14ARF and p53 expression and biological behavior of pancreatic carcinoma].
    Chen XL; Zhang QH; Ni QX
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):868-71. PubMed ID: 12895341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer.
    Geisler SA; Olshan AF; Weissler MC; Cai J; Funkhouser WK; Smith J; Vick K
    Clin Cancer Res; 2002 Nov; 8(11):3445-53. PubMed ID: 12429633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: a comparison of two populations from different geographical regions.
    Sirigu P; Piras F; Minerba L; Murtas D; Maxia C; Colombari R; Corbu A; Perra MT; Ugalde J
    Eur J Histochem; 2006; 50(3):191-8. PubMed ID: 16920642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
    Karamitopoulou E; Tornillo L; Zlobec I; Cioccari L; Carafa V; Borner M; Schaffner T; Brunner T; Diamantis I; Zimmermann A; Terracciano L
    Am J Clin Pathol; 2008 Nov; 130(5):780-6. PubMed ID: 18854271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
    Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [P16 expression in lung cancer and its significance].
    Guo Y; Guan J; Ge B
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):354-5. PubMed ID: 10923439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
    de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
    Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.